Faster Isn’t Always Better
Developing a lateral flow assay (LFA) begins with the assumption that a faster flow is synonymous with better performance, meaning shorter test time and quicker decision-making. But for most lateral flow immunoassays, especially those targeting low-abundance biomarkers, excessively fast wicking directly compromises sensitivity. This leads to weak test-line signals or even false negatives. Conversely, overly slow membranes introduce background noise and are impractical in manufacturing and field use.
Axiflow’s nitrocellulose membranes span ~70–180 s/4 cm (AXC70, AXC90, AXC100, AXC115, AXC130, AXC160). They are engineered to provide a predictable, stable foundation for designing LFA assays or kits, especially when combined with our sample, conjugate, blood separation, and absorbent pads.
Calibrating an LFA involves defining the assay’s biological requirements, selecting the right membrane flow window, matching pads to support that flow, prototyping, and refining the chemistry and line architecture. Axiflow’s membranes and pads provide a consistent baseline that reduces flow-related variables.
This article shows how calibrating flow rate to assay biology, rather than pursuing the fastest membrane available, leads to better sensitivity, stronger reproducibility, and smoother scale-up.
Why Flow Rate Governs Sensitivity: The Biochemistry
Capillary-driven transport in nitrocellulose membranes depends on pore size distribution, surface energy, and wicking capacity. These parameters determine how quickly the sample front advances and how long analyte-conjugate complexes stay around the test line.
At the test line, the target analyte must bind to the immobilised capture molecules (usually antibodies or antigens that have been stripped onto the membrane). Binding efficiency depends on classic binding kinetics like kon and koff subscripts and dwell time. At low-analyte concentrations, as in early-stage viral or antigen detection, binding is diffusion- and probability-limited. The analyte needs enough time at the test line for stable complex formation.
- If flow is too fast:
- Dwell time decreases
- Efficiency of antibody capture drops
- The signal weakens, particularly at low analyte concentrations
- Repeatability is compromised because small variations in sample viscosity or pad wetting can amplify the loss of sensitivity
- If flow is too slow:
- The conjugate over-diffuses
- Non-specific interactions increase background noise
- Total test time might exceed acceptable clinical or market thresholds
This is why membrane engineering and coordinated tuning of sample pad uptake, conjugate release kinetics, and absorbent pad drive matters. Assay formulation alone cannot fully compensate for an inappropriate flow window.
Flow-Rate “Zones”: Fast, Moderate, and Slow in LFA Performance
In lateral flow development, a fast nitrocellulose membrane generally wicks at approximately 70–90 s/4 cm, making it suitable for high-analyte tests that need rapid results. Slow membranes are closer to 130–160 s/4 cm, and support high-sensitivity assays as there is higher dwell time.
It can help to think of wicking times as zones, each suited to specific assay requirements.
Fast-flow zone: Rapid sample advancement
Pros:
- Very short time-to-result
- Ideal for assays where analyte concentrations are routinely high
Cons:
- Limited dwell time may lead to challenges when analyte concentrations are low
- Susceptible to false negatives
Moderate-flow zone: Balanced, with moderate endpoint times
Pros:
- Often the optimal point for assays as it balances sensitivity with an acceptable test duration
- Good for typical infectious disease markers like dengue NS1 and malaria HRP2 that need a balanced dwell time to capture the antigen
Cons:
- Must ensure that conjugate release and membrane binding dynamics are synchronised
Slow-flow zone: Extended dwell time
Pros:
- Ideal for assays that need more time to capture the antigen
- Helps stabilise weak positives and improves line visibility
Cons:
- Longer runtime
- Possibility of background noise
In all cases, pad selection too matters. Even the best nitrocellulose membrane cannot perform correctly if the sample pad starves the strip, conjugate release is slow, or the absorbent pad cannot maintain capillary pull. Axiflow’s membranes and pads are specifically engineered to work together as a system, negating these problems.
Axiflow’s Membrane Portfolio and Pad System for Predictable Calibration
Flow Window Portfolio (70–180 s wicking)
Axiflow has a range of NC membranes:
- Fast: AXC70, AXC90
- Mid: AXC100, AXC115
- Slow: AXC130, AXC160
Each grade provides a stable, low-variance flow profile. This is important for predictable lateral flow assay development and to reduce troubleshooting.
What sets Axiflow’s nitrocellulose membrane profile apart is our commitment to:
Optimised pore architecture & surface chemistry
Tightly-controlled pore-size distributions and precise surface treatments means uniform flow, consistent particle transport, and reliable hydrophilicity.
High protein-binding capacity
High-capacity binding sites allow for antibody immobilisation and support strong signal development within each membrane’s flow window.
Stability across humidity and temperature
Axiflow membranes are engineered to maintain their flow characteristics across various manufacturing and storage conditions. That means fewer surprises during transfer.
Complementary pad system
Axiflow’s sample, conjugate, blood separation, and absorbent pads are matched to each membrane grade to ensure uniform sample uptake, smooth conjugate release, and consistent capillary drive across the strip.
Mapping Assay Types to Flow Profiles on Axiflow
Each assay ultimately requires empirical optimisation, but here are some strong starting points:
High-Analyte / Rapid Decision Tests → Fast Membranes (AXC70, AXC90)
Examples: pregnancy tests (hCG hormone), blood grouping assays (Rh/ABO antigens)
These assays typically have abundant analyte levels, so sensitivity is less of a concern. Fast membranes give quick results without compromising performance, provided that conjugate release and pad selection support the required flow rate.
High-Sensitivity Infectious Disease Markers → Slow Membranes (AXC130, AXC160)
Examples: HIV (p24 antigen, anti-HIV antibodies), Hepatitis B (HBsAg)
These are low-concentration analytes and thus require longer dwell times. Slow membranes help with stronger line visibility.
Fever Panel / Mid-Sensitivity Targets → Mid-Speed Membranes (AXC100, AXC115)
Examples: Malaria (HRP2/pLDH antigens), Dengue (NS1 antigen, IgM/IgG antibodies)
These assays must balance clinical urgency with moderate sensitivity requirements. Mid-range membranes produce reliable signal intensity with acceptable test duration, especially when sample matrices (e.g., whole blood) contain particulates that might overload slower membranes.
Practical Calibration Workflow with Axiflow
A structured approach helps accelerate optimisation and reduces the risk of flow-related troubleshooting later on in development.
- Define your assay requirements
Clarify analyte range, target sensitivity, expected matrix (serum, plasma, urine, whole blood), and acceptable time-to-result.
- Select candidate membrane grades
Choose membranes spanning the anticipated flow zone:
- Fast (AXC70/90)
- Mid (AXC100/115)
- Slow (AXC130/160)
- Match pads to the membrane
Use Axiflow sample pads, conjugate pads, blood separation pads, and absorbent pads tuned to the target flow behaviour.
- Prototype and evaluate
Monitor:
- T-line intensity
- Background levels
- Endpoint time
- Lot-to-lot consistency
- Use these observations to narrow the choices.
- Refine and lock
Once the flow window is set, refine your buffer systems, conjugate loading, and line architecture. Keeping the membrane grade constant during this stage helps improve reproducibility and reduces risk during scale-up.
Before locking an assay design, verify:
- Does the analyte concentration need more dwell time?
- Is background increasing due to an overly slow flow?
- Are the line intensities consistent across multiple lots?
- Are the pads appropriately matched to the membrane to avoid flow bottlenecks?
Using Axiflow membranes and pads as a stable baseline ensures that you are optimising on assay chemistry, and not just compensating for inconsistent flow behavior.
Conclusion: Designing for Sensitivity, Not Just Speed
In lateral flow immunoassays, speed must always be balanced with sensitivity, reproducibility, and robustness. Axiflow’s nitrocellulose membrane portfolio, from fast (AXC70/90) to mid (AXC100/115) to slow (AXC130/160), combined with Axiflow’s matched pad system, gets this balance right and gives assay developers a controlled, predictable foundation for building lateral flow devices.
Choosing the right flow zone and calibrating your lateral flow assays systematically with Axiflow can help your assay development teams improve sensitivity, reduce variability, and produce high-quality LFAs that perform reliably in real-world conditions.